tiprankstipranks
Cadrenal Therapeutics, Inc. (CVKD)
:CVKD
US Market

Cadrenal Therapeutics, Inc. (CVKD) Financial Statements

Compare
275 Followers

Cadrenal Therapeutics, Inc. Financial Overview

Cadrenal Therapeutics, Inc.'s market cap is currently $34.27M. The company's EPS TTM is $-7.299; its P/E ratio is ―; Cadrenal Therapeutics, Inc. is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-1.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ -1.98K$ -1.27K
Operating Income$ -7.63M$ -2.70M
EBITDA$ -8.34M$ -6.61M
Net Income$ -8.36M$ -6.71M
Balance Sheet
Cash & Short-Term Investments$ 8.40M$ 32.59K
Total Assets$ 8.52M$ 778.17K
Total Debt$ 21.35K$ 640.71K
Net Debt$ -8.38M$ 608.12K
Total Liabilities$ 826.88K$ 6.33M
Stockholders' Equity$ 7.69M$ -5.55M
Cash Flow
Free Cash Flow$ -3.53M$ -1.20M
Operating Cash Flow$ -3.53M$ -1.20M
Investing Cash Flow$ -3.25K$ -2.28K
Financing Cash Flow$ 11.90M$ 1.24M
Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

Cadrenal Therapeutics, Inc. Debt to Assets

Cadrenal Therapeutics, Inc. Cash Flow

Cadrenal Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis